About this Journal Submit a Manuscript Table of Contents
Clinical and Developmental Immunology
Volume 2012 (2012), Article ID 354594, 6 pages
http://dx.doi.org/10.1155/2012/354594
Clinical Study

Carbonic Anhydrases III and IV Autoantibodies in Rheumatoid Arthritis, Systemic Lupus Erythematosus, Diabetes, Hypertensive Renal Disease, and Heart Failure

1Department of Clinical Laboratory, Xuanwu Hospital, Capital Medical University, 45 Changchun Road, Beijing 100053, China
2Department of Oncology, Dongfang Hospital, Beijing University of Chinese Medicine, Beijing 100078, China
3Department of Clinical Immune, Xiangya School of Medicine, Central South University, Changsha 410078, Hunan, China

Received 8 July 2012; Accepted 14 August 2012

Academic Editor: Dimitrios Bogdanos

Copyright © 2012 Chengeng Liu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. Martínez-Borra and C. López-Larrea, “Autophagy and self-defense,” Advances in Experimental Medicine and Biology, vol. 738, pp. 169–184, 2012.
  2. Z. Kaya, C. Leib, and H. A. Katus, “Autoantibodies in heart failure and cardiac dysfunction,” Circulation Research, vol. 110, no. 1, pp. 145–158, 2012. View at Publisher · View at Google Scholar
  3. C. T. Supuran, “Carbonic anhydrases: novel therapeutic applications for inhibitors and activators,” Nature Reviews Drug Discovery, vol. 7, no. 2, pp. 168–181, 2008. View at Publisher · View at Google Scholar · View at Scopus
  4. Y. Sherer, A. Gorstein, M. J. Fritzler, and Y. Shoenfeld, “Autoantibody explosion in systemic lupus erythematosus: more than 100 different antibodies found in SLE patients,” Seminars in Arthritis and Rheumatism, vol. 34, no. 2, pp. 501–537, 2004. View at Publisher · View at Google Scholar · View at Scopus
  5. H. Hosoda, M. Okawa-Takatsuji, W. Shinmura, N. Hasimoto, Y. Ozaki, and Y. Ikeda, “Potential for differential diagnosis of autoimmune pancreatitis and pancreatic cancer using carbonic anhydrase II antibody,” Pancreas, vol. 37, no. 1, pp. e1–e7, 2008. View at Publisher · View at Google Scholar · View at Scopus
  6. M. Sánchez-Castañón, G. de las Heras-Castaño, and M. López-Hoyos, “Autoimmune pancreatitis: an underdiagnosed autoimmune disease with clinical, imaging and serological features,” Autoimmunity Reviews, vol. 9, no. 4, pp. 237–240, 2010. View at Publisher · View at Google Scholar · View at Scopus
  7. S. R. Räisänen, P. Lehenkari, M. Tasanen, P. Rahkila, P. L. Härkönen, and H. K. Väänänen, “Carbonic anhydrase III protects cells from hydrogen peroxide-induced apoptosis,” FASEB Journal, vol. 13, no. 3, pp. 513–522, 1999. View at Scopus
  8. U. J. P. Zimmerman, P. Wang, X. Zhang, S. Bogdanovich, and R. E. Forster, “Anti-oxidative response of carbonic anhydrase III in skeletal muscle,” IUBMB Life, vol. 56, no. 6, pp. 343–347, 2004. View at Publisher · View at Google Scholar · View at Scopus
  9. G. J. Schwartz, J. Olson, A. M. Kittelberger, T. Matsumoto, A. Waheed, and W. S. Sly, “Postnatal development of carbonic anhydrase IV expression in rabbit kidney,” American Journal of Physiology, vol. 276, no. 4, part 2, pp. F510–F520, 1999. View at Scopus
  10. S. Breton, “The cellular physiology of carbonic anhydrases,” Journal of the Pancreas, vol. 2, no. 4, pp. 159–164, 2001. View at Scopus
  11. R. D. Vaughan-Jones, K. W. Spitzer, and P. Swietach, “Spatial aspects of intracellular pH regulation in heart muscle,” Progress in Biophysics and Molecular Biology, vol. 90, no. 1–3, pp. 207–224, 2006. View at Publisher · View at Google Scholar · View at Scopus
  12. W. Li, W. Wang, and S. Sun, “Autoantibodies against the catalytic domain of BRAF are not specific serum markers for rheumatoid arthritis,” PLoS One, vol. 6, no. 12, article e28975, 2011.
  13. A. Alver, A. Şentürk, H. Çakirbay, et al., “Carbonic anhydrase II autoantibody and oxidative stress in rheumatoid arthritis,” Clinical Biochemistry, vol. 44, no. 17-18, pp. 1385–1389, 2011.
  14. U. K. Biswas and A. Kumar, “Study on the changes of carbonic anhydrase activity in insulin resistance and the effect of methylglyoxal,” Journal of the Pakistan Medical Association, vol. 62, no. 5, pp. 417–421, 2012.
  15. G. Sanyal, E. R. Swenson, N. I. Pessah, and T. H. Maren, “The carbon dioxide hydration activity of skeletal muscle carbonic anhydrase. Inhibition by sulfonamides and anions,” Molecular Pharmacology, vol. 22, no. 1, pp. 211–220, 1982. View at Scopus
  16. M. C. Mitterberger, G. Kim, U. Rostek, et al., “Carbonic anhydrase III regulates peroxisome proliferator-activated receptor-γ2,” Experimental Cell Research, vol. 318, no. 8, pp. 877–886, 2012.
  17. A. Carrière, M. C. Carmona, Y. Fernandez et al., “Mitochondrial reactive oxygen species control the transcription factor CHOP-10/GADD153 and adipocyte differentiation: a mechanism for hypoxia-dependent effect,” Journal of Biological Chemistry, vol. 279, no. 39, pp. 40462–40469, 2004. View at Publisher · View at Google Scholar · View at Scopus
  18. L. W. Stanton, P. A. Ponte, R. T. Coleman, and M. A. Snyder, “Expression of CA III in rodent models of obesity,” Molecular Endocrinology, vol. 5, no. 6, pp. 860–866, 1991. View at Scopus
  19. J. D. Piganelli and M. M. Delmastro, “Oxidative stress and redox modulation potential in type 1 diabetes,” Clinical and Developmental Immunology, vol. 2011, Article ID 593863, 15 pages, 2011. View at Publisher · View at Google Scholar · View at Scopus
  20. B. Arcidiacono, S. Iiritano, A. Nocera, et al., “Insulin resistance and cancer risk: an overview of the pathogenetic mechanisms,” Experimental Diabetes Research, vol. 2012, Article ID 789174, 12 pages, 2012. View at Publisher · View at Google Scholar
  21. J. M. McCord and M. A. Edeas, “SOD, oxidative stress and human pathologies: a brief history and a future vision,” Biomedicine and Pharmacotherapy, vol. 59, no. 4, pp. 139–142, 2005. View at Publisher · View at Google Scholar · View at Scopus
  22. E. Cabiscol and R. L. Levine, “The phosphatase activity of carbonic anhydrase III is reversibly regulated by glutathiolation,” Proceedings of the National Academy of Sciences of the United States of America, vol. 93, no. 9, pp. 4170–4174, 1996. View at Publisher · View at Google Scholar · View at Scopus
  23. B. Arcidiacono, S. Iiritano, A. Nocera, et al., “Insulin resistance and cancer risk: an overview of the pathogenetic mechanisms,” Experimental Diabetes Research, vol. 2012, Article ID 789174, 2012.
  24. H. Yamada, “Current perspectives on the role of IL-17 in autoimmune disease,” Journal of Inflammation Research, vol. 3, no. 1, pp. 33–44, 2010. View at Scopus
  25. N. Lorenzo, A. Barberá, M. C. Domínguez, et al., “Therapeutic effect of an altered peptide ligand derived from heatshock protein 60 by suppressing of inflammatory cytokines secretion in two animal models of rheumatoid arthritis,” Autoimmunity, vol. 45, no. 6, pp. 449–459, 2012.
  26. D. J. Cua, J. Sherlock, Y. Chen et al., “Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain,” Nature, vol. 421, no. 6924, pp. 744–748, 2003. View at Publisher · View at Google Scholar · View at Scopus
  27. G. Sanyal, E. R. Swenson, N. I. Pessah, and T. H. Maren, “The carbon dioxide hydration activity of skeletal muscle carbonic anhydrase. Inhibition by sulfonamides and anions,” Molecular Pharmacology, vol. 22, no. 1, pp. 211–220, 1982. View at Scopus